Skip to main navigation Skip to search Skip to main content

Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

  • Local Health Authority Asl Roma 1

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalVaccines
DOIs
Publication statusPublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • SARS-CoV-2
  • booster
  • health personnel
  • immunity
  • mRNA vaccine
  • vaccination

Cite this